Navigation Links
London Luxury LLC Announces Exclusive Partnership with Cupron, Inc., to Develop Innovative Copper-Infused Bed and Bath Products
Date:4/7/2008

London Luxury Named Exclusive Manufacturer of Home Textile Products for the

Cupron Brand, Major Product Launch Set For Second Half of 2008

NEW YORK, April 7, 2008 /PRNewswire/ -- London Luxury LLC, a leading manufacturer of innovative and premium home textile products, today announced a major licensing agreement with Cupron, Inc., a company whose breakthrough, patented technology uniquely binds copper to textile fibers, to allow for the production of fabric containing copper-infused fibers. Copper's natural properties are scientifically and clinically proven to penetrate into the skin, leaving its appearance healthier, glowing and more beautiful.

Under the terms of the agreement, London Luxury will become the exclusive home textiles manufacturer for Cupron's proprietary copper technology -- marketed under the Cupron brand. London Luxury will create a complete line of copper-infused bed and bath products designed to promote healthier-looking skin, enhance the overall look of skin, and reduce the appearance of wrinkles and crows feet. When in contact with skin, the copper ions in the fibers will work to improve the skin's natural appearance-enhancing processes. Since the copper is embedded deep into the fabric, it never washes out and lasts for the life of the product. The collection will include premium quality sheets, pillows, pillow protectors, pillow cases, comforters, and blankets of all sizes, as well as bath and beach towels, robes, slippers, and bath rugs.

"Copper found in the body is an essential nutrient for the skin. Scientific testing has demonstrated a dramatically significant reduction of the appearance of facial wrinkles, crows feet, fine lines, and improvements in overall appearance of facial skin when sleeping on Cupron every night for four weeks," Dr. Gadi Borkow Ph.D., Chief Medical Scientist, Cupron."

"London Luxury's Cupron copper-infused bed and bath products are designed using Cupron's state-of-the-art patented copper technology to harnesses the power of copper-nature's own essential skin nutrient," said Marc Jason, CEO of London Luxury. "Cupron's remarkable technology combined with our obsession with innovation and quality will surely give new meaning to the concept of beauty sleep."

In addition to the cosmetic benefits of Cupron, the fabric and fibers are scientifically proven to kill the bacteria, fungus, and microbes that cause odor.

"London Luxury's is committed to cutting edge innovation and will continue to work with Cupron's remarkable technology to develop products which cater to the needs of industries such skin care, oil, healthcare, hospitality, and travel," continued Jason.

"London Luxury is Cupron's exclusive partner in the home category because they are the clear industry leader in beneficial bedding," said Jeff Gabbay, CEO of Cupron. "Time and time again, they have proven that they can successfully manufacture, distribute, and market products that are of the highest and most luxurious quality while still providing important benefits to consumers. We are confident that London Luxury's bed and bath products featuring Cupron technology will not only prove to be wildly successful with consumers, but game changing for the industry."

The launch of London Luxury's Cupron copper-infused bedding and bath collection is scheduled for the second half of 2008 at a major retailer, nationwide.

About London Luxury LLC

London Luxury LLC is one of the nation's leading manufacturers of innovative and premium textile products for the home. The company is based in New Rochelle, New York with a showroom in New York City. For more information please visit http://www.londonlux.com

ABOUT CUPRON INC.

Utilizing the ancient and unique properties of copper, Cupron has developed a groundbreaking technology for enhancing the skin's natural healthy-appearance promoting processes, deodorizing naturally, and fighting stain-causing microbes in textile fibers, non-woven fabrics, paper, latex and other polymeric products. By binding copper oxide to the fibers and compounds that make up every day products, Cupron offers a broad platform technology that can enhance the capabilities of these items for the life of the product. Cupron is committed to being a green company using recycled, non-sensitizing and non-irritating, and natural copper because of its environmentally friendly nature. Cupron's copper-based technology has been proven in clinical trials, published in scientific journals, and has many potential groundbreaking applications. Cupron maintains its headquarters and R&D center in Bet Shemesh, Israel, with sales and marketing offices in North Carolina, Virginia and various countries in Europe.

Media Contacts:

Samantha Freeman

Kwittken & Company

646.747.7147

sfreeman@kwitco.com

Anna Faktorovich

London Luxury

914.636.2100

afaktorovich@londonlux.com


'/>"/>
SOURCE London Luxury LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. London Luxury Receives Asthma & Allergy Friendly(TM) Certification for Several of Its Bedding Products
2. Barrs PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange
3. MEDIA ALERT: Eularis to Address Marketing Return at Measuring Marketing ROI in Pharma Conference in London
4. Hospira to Present at the Bear Stearns 10th Annual London Healthcare Conference on March 13
5. Old London Launches Skinny Jeans Contest
6. Parker Waichman Alonso LLP, Becnel Law Firm, LLC, Douglas & London P.C., Levin
7. DaVita Nurse Gives Keynote Speech to St. Georges Hospital Vascular Access Annual Meeting in London
8. Prestigious London Hospital Enters Long-Term Agreement with Varian Medical Systems
9. Capps to Lead Bipartisan Womens Caucus Congressional Delegation to Represent United States at Women Deliver Conference in London
10. Prime Minister views innovative health technology at Imperial College London
11. London School of Hygiene to play key role in global collaboration on adverse drug reactions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
Breaking Medicine Technology: